A2A Pharmaceuticals, Inc. (CIK 0001859061)

Latest company ownership

Role: 10% Owner
Shares held
3,500,000
Last filed at
Jun 2, 2023
Confidence Score
50.0
2025Q4
Confidence Score History
2021Q3 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
May 31, 2023 Jun 2, 2023 Biomea Fusion, Inc. 10% Owner Sell 17.5 -125,000 -3.45% $4.3M
May 12, 2023 May 17, 2023 Biomea Fusion, Inc. 10% Owner Sell 30.0 -25,000 -0.68% $846K
May 8, 2023 May 10, 2023 Biomea Fusion, Inc. 10% Owner Sell 16.3 -250,000 -6.41% $8.6M
Apr 20, 2023 Apr 26, 2023 Biomea Fusion, Inc. 10% Owner Sell 16.3 -200,000 -4.88% $5.8M
Mar 31, 2023 Apr 6, 2023 Biomea Fusion, Inc. 10% Owner Sell 16.3 -200,000 -4.65% $6.3M
Mar 31, 2023 Apr 6, 2023 Biomea Fusion, Inc. 10% Owner Buy 96.3 +200,000 5.13% $6.3M
Aug 16, 2022 Aug 19, 2022 Biomea Fusion, Inc. 10% Owner Sell 30.0 -30,684 -0.71% $425.6K
Jul 21, 2022 Jul 25, 2022 Biomea Fusion, Inc. 10% Owner Sell 30.0 -34,658 -0.79% $388.5K
Jun 24, 2022 Jun 28, 2022 Biomea Fusion, Inc. 10% Owner Sell 30.0 -34,658 -0.79% $407.6K
Sep 17, 2021 Sep 21, 2021 Biomea Fusion, Inc. 10% Owner Buy 75.0 +34,658 0.79% $379.9K